Please Wait
Applying Filters...
menu
    • menu
    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Enlicitide

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck's Enlicitide Decanoate Reduces LDL-C In HeFH Adults
    Merck's Enlicitide Decanoate Reduces LDL-C In HeFH Adults

    09 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251109011682/en/Mercks-Enlicitide-Decanoate-an-Investigational-Oral-PCSK9-Inhibitor-Significantly-Reduced-LDL-C-in-Adults-with-Heterozygous-Familial-Hypercholesterolemia-HeFH-in-Phase-3-CORALreef-HeFH-Trial

    BUSINESSWIRE
    09 Nov 2025
    Share Share
    Merck Enlicitide Decanoate Lowers LDL-C In Ph3 CORALreef Trial
    Merck Enlicitide Decanoate Lowers LDL-C In Ph3 CORALreef Trial

    08 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251108607082/en/Mercks-Enlicitide-Decanoate-an-Investigational-Oral-PCSK9-Inhibitor-Significantly-Reduced-LDL-C-in-Phase-3-CORALreef-Lipids-Trial

    BUSINESSWIRE
    08 Nov 2025
    Share Share